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Abstract
DNA microarrays are a powerful tool for monitoring thousands of transcript levels simultaneously. However, the use of DNA
microarrays in studying the central nervous system faces several challenges. These include the detection of low-abundance
transcripts in highly complex tissue as well as estimating relatively low-magnitude changes in transcript levels in response to
experimental manipulation. Many transcripts important to brain function have low expression levels or are expressed in relatively
few cells, making them dif®cult to detect in the complex background of brain tissue. The aim of the present study is to evaluate
the sensitivity of Gene Chip detection of transcripts in brain by using results from serial analysis of gene expression (SAGE)
studies. The results of this comparison indicate that Affymetrix Gene Chips, like SAGE, only reliably detect medium- to high-
abundance transcripts and that detection of low-abundance transcripts, many of which have great relevance to biological function
in brain, is inconsistent. Speci®cally, we estimate that Gene Chips reliably detect no more than 30% of the hippocampal
transcriptome when using a gross hippocampal dissection as the source tissue. This report provides the ®rst broad evaluation of
Affymetrix Gene Chip sensitivity relevant to studying the brain.
Introduction
DNA microarrays are used to measure the relative expression levels
of thousands of transcripts to enable global analysis of biological
systems and have lead to important discoveries, described in several
reviews, in the ®elds of cancer (Clarke et al., 2001), pathology (Kato-
Maeda et al., 2001), antimicrobial drug discovery (Ivanov et al.,
2000) and neuroscience (Cao & Dulac, 2001). However, the limits of
DNA microarray technology have not been well described and the
use of DNA microarrays to study the brain faces signi®cant
challenges with regard to sensitivity, largely because of the high
complexity of neuronal tissue.
Estimates have been made to predict the limit of sensitivity of
DNA microarrays. Speci®cally, Affymetrix, who manufacture Gene
Chips Ð a form of DNA microarrays, reports that Gene Chips can
reliably detect cRNA species in a hybridization cocktail at » 2 pM.
Using a homogenous cell population as the source of RNA this would
translate to » 1 copy per cell. However, this has little value in
determining the limits of detection of microarray technology in
complex tissue, like brain structures, where there are a large number
of specialized cells with variant transcriptional pro®les. Many
transcripts that are important for brain function are expressed at
low levels or in a relatively small number of cells. For example,
gonadotropin-releasing hormone (GnRH), which is imperative to
reproductive function, is only expressed in a few thousand cells
(Yellon et al., 1990) dispersed throughout the hypothalamus (King
et al., 1984). Analysis of hypothalamic RNA by Affymetrix U34A
Gene Chips only detects this transcript » 50% of the time when using
a gross hypothalamic dissection as the source tissue (our unpublished
data). This insensitivity presents signi®cant problems in successfully
monitoring expression level variations in response to experimental
manipulation of many biologically relevant transcripts.
Techniques to reduce tissue complexity, such as microdissection or
laser-capture microscopy (Emmert-Buck et al., 1996), are likely to
improve the detection of cell-speci®c transcripts by DNA micro-
arrays. These types of focused studies may indeed be the most
appropriate at times but in many cases speci®c cellular nuclei
important to a given experimental paradigm will not have been
identi®ed or the study of too many speci®c neuroanatomical areas by
microarray may not be feasible. Typically, successful DNA
microarray studies in brain have focused on discrete structures
followed by the use of anatomical techniques, such as in situ
hybridization (Mirnics et al., 2000; Sandberg et al., 2000; Mody et al.,
2001; Zhao et al., 2001; Zirlinger et al., 2001).
Serial analysis of gene expression (SAGE) is a high-throughput
sequencing-based technique used to estimate the relative expression
levels of thousands of transcripts by sequencing concatamers of short
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sequence tags derived from a biological sample (Velculescu et al.,
1995). The relative abundance of transcripts in the sample can be
estimated because it is proportional to the representation of the
transcripts by sequence tags in the SAGE data. This technique has
previously been used by Datson et al. (2001) to analyse the
transcriptome of the rat hippocampus, which is a complex hetero-
genous tissue composed of several morphologically distinct neuronal
and non-neuronal cell types. In this study, in which a total of 76 790
SAGE tags were analysed, the number of low-abundance transcripts
was shown to be far greater than the number of high-abundance
transcripts. In fact, transcripts of low abundance, detectable with 1±5
SAGE tags each in this study, represented 80% of the total number of
unique tags. Transcripts of intermediate abundance, with 6±50 tags,
represented 19% of the unique tags, while high-abundance transcripts
with > 50 tags represented only 1% of total unique tags detected.
Furthermore, annotation of transcripts in this study, to reveal
distribution of functional gene families with regard to expression
level, found that most genes contributing to functional specialization
of neuronal tissue are of relatively low abundance. For example,
neurotransmitter receptors, ion channels, synaptic components, signal
transduction machinery and transcription factors were generally
represented by few SAGE tags.
In the current study we have evaluated the ef®ciency of detection
of hippocampal transcripts by Affymetrix RG-U34A Gene Chips
using expression level estimates obtained by SAGE. Using this
analysis we were able to estimate the percentage of transcripts being
reliably detected by Gene Chips across various expression levels and
functional classes. This report provides the ®rst broad analysis of the
sensitivity of DNA microarray technology in the complex back-
ground of neuronal tissue.
Methods
Animals and tissue preparation
Male Sprague-Dawley rats from Charles River (Wilmington, MA,
USA), weighing 250±300 g, were used in this study. They were
housed three per cage in 43 3 21.5 3 25.5 cm plexiglass cages, and
kept on a 12-h light±dark cycle (lights off at 07.00 h). Food and water
were available ad libitum. All experiments were conducted in
accordance with the guidelines of the animal ethics committee at the
University of Michigan following the Guide for the Care and Use of
Laboratory Animals (National Research Council 1996). After
2 weeks of habituation to the housing conditions, the rats were
killed by decapitation between 11.00 and 13.00 h. The brains were
immediately removed, and hippocampi rapidly dissected and frozen.
Tissues were stored at ±80 °C until total RNA extraction.
Gene Chip studies
In total, 43 Affymetrix RG-U34A Gene Chips were hybridized with
cRNA derived from individual hippocampi from Sprague-Dawley
rats so that each Gene Chip represented the hippocampus of one rat.
Total RNA was extracted separately from individual hippocampi
using Trizol Reagent (Invitrogen, Carlsbad, CA, USA) per manufac-
turers instructions followed by a cleanup step using RNeasy RNA
puri®cation columns (Qiagen, Valencia, CA, USA). Using 10 mg total
RNA as determined by absorbance at 260 nm, ®rst and second strand
synthesis was performed per instructions in the Affymetrix
Expression Analysis Technical Manual, ver3 (Affymetrix, Santa
Clara, CA, USA). cRNA was synthesized using the Bioarray High
Yield RNA Transcript Labeling Kit (Enzo, New York, NY, USA) and
prepared for hybridization with RG-U34A Gene Chips per
FIG. 1. Detection ef®ciency of Affymetrix RG-U34A Gene Chips in the
detection of 1000 hippocampal transcripts, using expression level estimates
obtained by SAGE. SAGE studies are compared with analysis using 43
independent Affymetrix RG-U34A Gene Chips. (a) The overall ef®ciency in
detection of the 1000 transcripts by Gene Chips is shown independent of
abundance predicted by SAGE. (b) The average ef®ciency in detection of
transcripts by Gene Chips is plotted relative to their abundance predicted by
SAGE. Each bar represents the percentage of the time each transcript within
the given SAGE tag bin was detected across all 43 Gene Chips. (c) The
distribution of transcripts of varying abundance predicted by SAGE is
plotted relative to their detection by Gene Chips. The proportion of
transcripts within each SAGE tag bin falling into different degrees of
percentage detection by Gene Chips is shown.
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Affymetrix instructions. Gene Chips were hybridized for 18 h at
42 °C, washed and stained on an Affymetrix ¯uidics station using the
standard EukGEws2v3 protocol and scanned with a Gene Array
Scanner. Raw image data were quanti®ed with Affymetrix MAS 5.0
using all default threshold settings.
SAGE studies
SAGE data was derived from the results of the study by Datson et al.
using hippocampi from male Wistar rats (Datson et al., 2001). Unique
accession numbers from SAGE data were merged with Affymetrix
Gene Chip probe set identi®ers using ProbeMatchDB (Wang et al.,
2002).
Results
The results described below are derived from 1000 transcripts that
could be evaluated because they were unambiguous and common to
the SAGE and Gene Chip data sets. These are all of the transcripts
with a SAGE tag that was uniquely identi®ed by a single GenBank
accession number and was mapped to a single UniGene cluster (build
no. 96) that was represented on the RG-U34A array. This set of 1000
transcripts had a distribution through the various SAGE tag bins
similar to those described in the original SAGE study (Datson et al.,
2001) and is therefore assumed to be representative for the purpose of
the current study.
Figure 1a shows the overall detection ef®ciencies by Affymetrix
Gene Chips of the 1000 hippocampal transcripts. This ®gure
illustrates that Affymetrix Gene Chips reliably detect 41% and are
unable to detect 17% of these transcripts across all 43 Gene Chips
used in this study. The remaining 42% of transcripts are detected
somewhere between 0 and 100% of the time, as further detailed in the
®gure. Detection is de®ned as receiving a `present' or `marginal' call
from the Affymetrix MAS 5.0 software using the default settings,
which would identify any transcripts with a detection P-value of
< 0.06. The average detection P-values (across all 43 Gene Chips)
for the various bins detailed in the ®gure were 0.548, 0.285, 0.172,
0.070, 0.022 and 0.002 for the detection bins of 0, 1±25, 26±50, 51±
75, 76±99 and 100%, respectively.
Figure 1b shows the detection ef®ciency by Gene Chips of the
1000 unique transcripts relative to their abundance bins as described
by SAGE. These results show that the low-abundance transcripts,
represented by a single SAGE tag, were detected an average of 55%
of the time and that high-abundance transcripts, represented by > 50
SAGE tags, were detected an average of 90% of the time on
Affymetrix U34A arrays. Transcripts of intermediate abundance with
2±5, 6±10 and 11±50 SAGE tags were detected an average of 65, 85
and 88% of the time, respectively. It should be noted that transcripts
with a SAGE tag count of at least 5 in this study are considered
reliably detected by SAGE.
Figure 1c expands the SAGE tag abundance bins into their relative
distributions across detection ef®ciencies by Gene Chips. This ®gure
shows what percentage of transcripts from each SAGE tag bin was
reliably detected (by 100% of the Gene Chips), undetected (by 0% of
the Gene Chips), or detected unreliably (by between 0% and 100% of
the Gene Chips). In general, a higher proportion of tags were reliably
detected than were undetected or unreliably detected at all expression
levels analysed. For transcripts of low abundance, represented by 1±5
SAGE tags, the undetected category was the second largest whereas,
for the intermediate-abundance transcripts, represented by 6±50
SAGE tags, the intermediate detection ef®ciency categories were the
second largest. Transcripts of high abundance, with > 50 SAGE tags,
were never completely undetected by Gene Chips. To summarize, the
detection ef®ciency of Gene Chips, in general, increased with the
SAGE tag count. However, there were a high percentage of
transcripts reliably detected by Gene Chips at all expression levels
estimated by SAGE.
The glutamate system is known to play a key role in hippocampal
function (Kullmann & Asztely, 1998; Bortolotto et al., 1999), which
is exempli®ed by the fact that glutamate receptors were the most
frequently observed class of neurotransmitter receptors in the SAGE
study (Datson et al., 2001). To illustrate how an entire system is
detected in the context of these broad analysis tools, we focus on the
known components of the glutamate system that are found in both the
SAGE and Gene Chip data sets. Table 1 highlights these transcripts
and reports both their SAGE tag count and their ef®ciency of
detection by Gene Chips. This table shows that increased SAGE tag
count generally predicts increased Gene Chip detection ef®ciency
within this system, as is the case for transcripts in general.
Examination of the transcripts listed in the table show that many
receptors are expressed at low levels and are outside the range of
reliable detection for both techniques, whereas the transporter and
synthesis machineries are expressed at higher levels and more
reliably detected. Although the detection by SAGE and Gene Chips
correlates quite well, there are some differences. For example,
metabotropic glutamate receptor 3, kainate receptor subunit ka2 and
glutamate transporter GluT are reliably detected by Gene Chips but
not reliably detected by SAGE (< 5 tags) whereas NMDAR1 is
reliably detected by SAGE (> 5 tags) but not reliably detected by
Gene Chips.
Discussion
In this study we evaluated the sensitivity of Affymetrix Gene Chips in
a complex neuronal tissue, the hippocampus. These studies show that
relatively high-abundance transcripts are reliably detected by Gene
Chips but that a signi®cant percentage of low-abundance transcripts
are undetected or unreliably detected. In addition, a vast majority of
expressed transcripts in the hippocampus fall into the low-abundance
category. This work is important because DNA microarray studies are
currently being used to provide a global view of the transcriptome
and the current study estimates the degree to which this approach is
successful in brain tissue.
Although there is a strong correlation between the expression level
of a transcript predicted by SAGE and the detectability of the
transcript by Affymetrix Gene Chips the relationship is not strict. The
data show that Gene Chip probes complementary to transcripts
expressed at similar estimated expression levels do not necessarily
perform equally. Gene Chips may under-perform due to probe design
issues, such as: distance of the target sequence from the poly-A tail;
secondary structures within the target sequence; and cross-reactivity
of the probe with other transcripts, each of which may in¯uence
detection. On the other hand, SAGE may under-perform because
speci®c transcripts may be missed due to the absence of a recognition
site for the anchoring enzyme or GC-content bias (Margulies et al.,
2001). In addition, incorrect tag counts can arise from incomplete
digestion or alternative polyadenylation, giving rise to multiple tags
derived from a single transcript. Also, sequencing errors, especially in
the population of tags encountered only once, can contribute to the
differences between SAGE and Gene Chip data.
Besides technical explanations, a biological explanation for
observed differences between Gene Chip and SAGE data might be
that male Wistar rats were used in the SAGE study and male Sprague-
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Dawley rats were used in the Gene Chip studies. Although this may
have a small impact on the conclusions drawn below, it is unlikely
that it will be signi®cant because these two strains of rats are closely
related, as is evident by the overall good correlation in this study
between the SAGE and Gene Chip data sets. Supporting an
assumption of minimal strain differences, a study using Gene Chips
to examine brain expression pro®les of two different strains of mice
found < 1% of the genes investigated to be differentially expressed in
the hippocampus (Sandberg et al., 2000).
The SAGE data from rat hippocampus (Datson et al., 2001)
utilized by the current study is probably not a complete representation
of the hippocampal transcriptome. In fact, extrapolating the raw data
of unique tags identi®ed vs. tags analysed predicts that there are
» 66 000 unique sequence tags (R2 = 0.998) expressed by hippocam-
pus (data not shown). By these calculations the SAGE study under
discussion, which revealed 28 803 unique tags, detected » 41% of the
rat hippocampal transcriptome. Thus, calculations relating to the
percentage of transcripts detected by Affymetrix Gene Chips as
reported in the results section are likely to be overestimates when
considering the entire hippocampal transcriptome, because it is
probable that the remaining transcripts undetected in the SAGE
analysis would be skewed toward the low-abundance bins. Following
this logic, it is likely that a large percentage of the transcripts that
remain undetected by the SAGE study would also go undetected by
Gene Chips. If we assume that the transcripts undetected by SAGE
would be detected by Gene Chips no better than those transcripts
represented by a single SAGE tag, we can estimate that Affymetrix
Gene Chips reliably detect no more than 30% and fail to detect at
least 30% of hippocampal-expressed transcripts using a gross
hippocampal dissection as the source tissue. This leaves » 40% of
hippocampal transcripts falling into the range of unreliable detection.
This study suggests that Affymetrix DNA microarray technology
applied to neuroscience can only reliably reveal regulation of mRNA
species of medium to high abundance. This shortcoming applies to
SAGE as well, given that the overall sensitivity of the two
technologies in this study appeared similar.
The consequences of these limitations will obviously depend on
the system under investigation. For example, receptors are generally
expressed at lower levels than neurotransmitter/neuropeptide pro-
cessing machinery, as exempli®ed by the glutamate system in this
report. Although there will be many exceptions to this, the
consequences are that receptor regulation may be more dif®cult to
detect by DNA microarrays than regulation of the more abundant
synthesis or signal transduction machinery. However, a small number
of insights into system regulation generated by DNA microarrays can
lead to further discoveries within speci®c pathways by classical
studies, such as in situ hybridization or immunocytochemistry.
To conclude, current DNA microarray technology is not likely to
reveal regulation of low-abundance transcripts, which represent a
large percentage of the transcriptome in complex tissue. However,
provided that the limits of Gene Chips are understood, the technology
does provide a powerful, state-of-the-art tool to analyse brain
transcriptional pro®les and can successfully lead to important
discoveries by more focused studies of speci®c systems using other
techniques.
Acknowledgements
SAGE experiments were supported by the Netherlands Organization for
Scienti®c Research, Grants 903-42-085 and 925-01-008. Gene chip experi-
ments were supported by the Nancy Pritzker Depression Research Network
and the National Institute of Mental Health, Program Project Grant 5 P01
MH42251.
Abbreviation
SAGE, serial analysis of gene expression.
References
Bortolotto, Z.A., Fitzjohn, S.M. & Collingridge, G.L. (1999) Roles of
metabotropic glutamate receptors in LTP and LTD in the hippocampus.
Curr. Opin. Neurobiol., 9, 299±304.
Cao, Y. & Dulac, C. (2001) Pro®ling brain transcription: neurons learn a
lesson from yeast. Curr. Opin. Neurobiol., 11, 615±620.
Clarke, P.A., te Poele, R., Wooster, R. & Workman, P. (2001) Gene
expression microarray analysis in cancer biology, pharmacology, and drug
development: progress and potential. Biochem. Pharmacol., 62, 1311±1336.
Datson, N.A., van der Perk, J., de Kloet, E.R. & Vreugdenhil, E. (2001)
TABLE 1. Expression level estimates by SAGE and detection ef®ciency by gene chips of hippocampal glutamate system components
Accession no. SAGE tag count Gene chip detection (%) Description
M91652 38 100 Glutamine synthetase (glnA)
M38061 19 100 Glutamate receptor (GluR-B)
D63772 9 100 Neuronal high-af®nity glutamate transporter
M92076 1 100 Metabotropic glutamate receptor 3
Z11581 2 98 Kainate receptor subunit (ka2)
U15098 1 98 GluT and GluT-R glutamate transporter
X63744 2 74 Glutamate/aspartate transporter
D87839 2 63 Beta-alanine oxoglutarate aminotransferase
U11418 6 53 NMDAR1 glutamate receptor subunit
Z11548 2 49 Glutamate receptor subunit (GluR6), kainate subtype
X54656 1 47 Glutamate receptor subunit (GluR-K3)
M83561 1 44 Glutamate receptor subunit 5±2 (GluR5-2), kainate subtype
U08260 2 28 NMDAR2D glutamate receptor subunit
X17184 4 21 Glutamate receptor, AMPA subtype, GluR1
U08255 2 14 Glutamate receptor delta-1 subunit
D13212 1 12 NMDAR2C glutamate receptor subunit
D13213 2 0 NMDAR2D-1 glutamte receptor subunit
AF027331 1 0 Kainate receptor GluR7b
The table highlights the components of the glutamate system that were uniquely detected by SAGE and represented on Affymetrix RG-U34A gene chips. The
SAGE tag count and the detection ef®ciency by gene chips is reported.
412 S. J. Evans et al.
ã 2002 Federation of European Neuroscience Societies, European Journal of Neuroscience, 16, 409±413
Expression pro®le of 30,000 genes in rat hippocampus using SAGE.
Hippocampus, 11, 430±444.
Emmert-Buck, M.R., Bonner, R.F., Smith, P.D., Chuaqui, R.F., Zhuang, Z.,
Goldstein, S.R., Weiss, R.A. & Liotta, L.A. (1996) Laser capture
microdissection. Science, 274, 998±1001.
Ivanov, I., Schaab, C., Planitzer, S., Teichmann, U., Machl, A., Theml, S.,
Meier-Ewert, S., Seizinger, B. & Loferer, H. (2000) DNA microarray
technology and antimicrobial drug discovery. Pharmacogenomics, 1, 169±
178.
Kato-Maeda, M., Gao, Q. & Small, P.M. (2001) Microarray analysis of
pathogens and their interaction with hosts. Cell Microbiol., 3, 713±719.
King, J.C., Anthony, E.L., Gustafson, A.W. & Damassa, D.A. (1984)
Luteinizing hormone-releasing hormone (LH-RH) cells and their
projections in the forebrain of the bat Myotis lucifugus lucifugus. Brain
Res., 298, 289±301.
Kullmann, D.M. & Asztely, F. (1998) Extrasynaptic glutamate spillover in the
hippocampus: evidence and implications. Trends Neurosci., 21, 8±14.
Margulies, E.H., Kardia, S.L. & Innis, J.W. (2001) Identi®cation and
prevention of a GC content bias in SAGE libraries. Nucl. Acids Res., 29,
E60±E60.
Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A. & Levitt, P. (2000)
Molecular characterization of schizophrenia viewed by microarray analysis
of gene expression in prefrontal cortex. Neuron, 28, 53±67.
Mody, M., Cao, Y., Cui, Z., Tay, K.Y., Shyong, A., Shimizu, E., Pham, K.,
Schultz, P., Welsh, D. & Tsien, J.Z. (2001) Genome-wide gene expression
pro®les of the developing mouse hippocampus. Proc. Natl Acad. Sci. USA,
98, 8862±8867.
Sandberg, R., Yasuda, R., Pankratz, D.G., Carter, T.A., Del Rio, J.A.,
Wodicka, L., Mayford, M., Lockhart, D.J. & Barlow, C. (2000) Regional
and strain-speci®c gene expression mapping in the adult mouse brain. Proc.
Natl Acad. Sci. USA, 97, 11038±11043.
Velculescu, V.E., Zhang, L., Vogelstein, B. & Kinzler, K.W. (1995) Serial
analysis of gene expression. Science, 270, 484±487.
Wang, P., Ding, F., Chiang, H., Thompson, R.C., Watson, S.J. & Meng, F.
(2002) ProbeMatchDB-a web database for ®nding equivalent probes across
microarray platforms and species. Bioinformatics, 18, 488±489.
Yellon, S.M., Lehman, M.N. & Newman, S.W. (1990) The gonadotropin-
releasing hormone neuronal system of the male Djungarian hamster:
distribution from the olfactory tubercle to the medial basal hypothalamus.
Neuroendocrinology, 51, 219±225.
Zhao, X., Lein, E.S., He, A., Smith, S.C., Aston, C. & Gage, F.H. (2001)
Transcriptional pro®ling reveals strict boundaries between hippocampal
subregions. J. Comp. Neurol., 441, 187±196.
Zirlinger, M., Kreiman, G. & Anderson, D.J. (2001) Amygdala-enriched genes
identi®ed by microarray technology are restricted to speci®c amygdaloid
subnuclei. Proc. Natl Acad. Sci. USA, 98, 5270±5275.
Evaluation of Affymetrix gene chip sensitivity 413
ã 2002 Federation of European Neuroscience Societies, European Journal of Neuroscience, 16, 409±413
